Quality of Life Predictors in Chronic Stable Post-Stroke Patients and Prognostic Value of SF-36 Score as a Mortality Surrogate

Translational Stroke Research

Volumn 6, Issue 5, 2015, Pages 375-383

  Kielbergerová, Lenka ^a   Mayer, Otto ^a,b   Vaněk, Jiří ^a   Bruthans, Jan ^a,b   Wohlfahrt, Peter ^b,c   Cífková, Renata ^b,c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Depression; Ischemic stroke; Mortality; Quality of life, anxiety; SF 36 score

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ANXIETY; ARTICLE; BLOOD PRESSURE; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR DYSFUNCTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; RANKIN SCALE; RISK FACTOR; SHORT FORM 36; STROKE PATIENT; CHRONIC DISEASE; COMPLICATION; HEALTH SURVEY; KAPLAN MEIER METHOD; METABOLISM; PROGNOSIS; PSYCHOLOGY; STROKE;

AGED; ANXIETY; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HEALTH SURVEYS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS; STROKE;

EID: 84941175956     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-015-0418-6     Document Type: Article

References (29)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.
2. Kjellström T, Norrving B, Shatchkute A. Helsingborg Declaration 2006 on European stroke strategies. Cerebrovasc Dis. 2007;23:231–41.
3. Adams Jr HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655–711.
4. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160–236.
5. De Backer G, Ambrossioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention on clinical practice. Third joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J. 2003;24:1601–10.
6. Carod-Artal FJ. Determining quality of life in stroke survivors. Expert Rev Pharmacoecon Outcomes Res. 2012;12:199–211.
7. De Ryck A, Brouns R, Fransen E, Geurden M, Van Gestel G, Wilssens I, et al. A prospective study on the prevalence and risk factors of poststroke depression. Cerebrovasc Dis Extra. 2013;3:1–13.
8. Heuschmann PU, Kircher J, Nowe T, Dittrich R, Reiner Z, Cifkova R, et al. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey. Eur J Prev Cardiol. 2014 Aug 19. [Epub ahead of print]
9. The World Health Organization. The WHO Steps Manual. The WHO stepwise approach to the stroke surveillance. Geneva, Switzerland. 2006, available at: http://www.who.int/chp/steps/Manual.pdf
10. Bruno A, Shah N, Lin C, Close B, Hess DC, Davis K, et al. Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke. 2010;41:1048–50.
11. Gresham GE, Phillips TF, Labi ML. ADL status in stroke: relative merits of three standard indexes. Arch Phys Med Rehabil. 1980;61:355–8.
12. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
13. Ware Jr JE, Kosinski M, Gandek B. SF-36 Health Survey: manual and interpretation guide. Lincoln RI: QualityMetric Inc; 2002.
14. Brenden CK, Hollander JE, Guss D, McCullough PA, Nowak R, Green G, et al. Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study. Am Heart J. 2006;151:1006–11.
15. Bukan RI, Møller AM, Henning MA, Mortensen KB, Klausen TW, Waldau T. Preadmission quality of life can predict mortality in intensive care unit—a prospective cohort study. J Crit Care. 2014;29:942–7.
16. Hofhuis JG, Spronk PE, van Stel HF, Schrijvers AJ, Bakker J. Quality of life before intensive care unit admission is a predictor of survival. Crit Care. 2007;11:78–9.
17. Welsh CH, Thompson KRN, Long-Krug S. Evaluation of patient-perceived health status using the Medical Outcomes Survey Short-Form 36 in an intensive care unit population. Crit Care Med. 1999;27:1466–71.
18. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 2003;24:1735–43.
19. Richards AM, Doughty R, Nicholls MG, MacMahon S, Sharpe N, Murphy J, et al. Australia-New Zealand Heart Failure Group. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol. 2001;37:1781–7.
20. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014–21.
21. Mayer Jr O, Šimon J, Plášková M, Cífková R, Trefil L. N-terminal pro B-type natriuretic peptide as prognostic marker for mortality in coronary patients without clinically manifest heart failure. Eur J Epidemiol. 2009;24:363–8.
22. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655–63.
23. Nigro N, Wildi K, Mueller C, Schuetz P, Mueller B, Fluri F, et al. BNP but not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events. PLoS One. 2014;9:e102704.
24. Shibazaki K, Kimura K, Iguchi Y, Aoki J, Sakai K, Kobayashi K. Plasma brain natriuretic peptide predicts death during hospitalization in acute ischaemic stroke and transient ischaemic attack patients with atrial fibrillation. Eur Neurol. 2011;18:165–9.
25. Whiteley W, Wardlaw J, Dennis M, Lowe G, Rumley A, Sattar N, et al. The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke. 2012;43:86–91.
26. Rost NS, Biffi A, Cloonan L, Chorba J, Kelly P, Greer D, et al. Brain natriuretic peptide predicts functional outcome in ischemic stroke. Stroke. 2012;43:441–5.
27. Pompili M, Venturini P, Campi S, Seretti ME, Montebovi F, Lamis DA, et al. Do stroke patients have an increased risk of developing suicidal ideation or dying by suicide? An overview of the current literature. CNS Neurosci Ther. 2012;18:711–21.
28. Vuletić V, Sapina L, Lozert M, Lezaić Z, Morović S. Anxiety and depressive symptoms in acute ischemic stroke. Acta Clin Croat. 2012;51:243–6.
29. Campbell Burton CA, Murray J, Holmes J, Astin F, Greenwood D, Knapp P. Frequency of anxiety after stroke: a systematic review andmeta-analysis of observational studies. Int J Stroke. 2013;8:545–59.